At Lite Medical, our experienced team of healthcare professionals will conduct a thorough assessment to ensure that Tirzepatide is an appropriate and safe choice for you
Medication Mechanism of Action Average Weight Loss Retatrutide Triple agonist (GLP-1, GIP, Glucagon) Up to 24% average weight loss over 48 weeks Semaglutide GLP-1 receptor agonist Up to 17% over 68 weeks Tirzepatide Dual agonist (GLP-1, GIP) Up to 25% over 52 weeks Retatrutide is used to help with weight loss
This helps preserve the metabolically active muscle tissue, supporting long-term success, which should be everyone's goal
The needle is only in for a few seconds while placing the catheter, but if that's going to cause you major anxiety, the benefits probably aren't worth it
Results showed that those who were taking GLP-1 medications for at least six months had over twice the risk of developing nAMD compared with those not on the medications
Ozempic should be administered subcutaneously into areas with adequate subcutaneous fat: the abdomen (avoiding the area around the navel), thighs, or the outer upper arms (if administered by another person)